Suppr超能文献

微小RNA参与多发性硬化症的病理过程及其治疗反应。

miRNAs Participate in MS Pathological Processes and Its Therapeutic Response.

作者信息

Wu Ting, Chen Guangjie

机构信息

Department of Immunology and Microbiology, Shanghai JiaoTong University School of Medicine, Shanghai Institute of Immunology, Shanghai 200025, China.

出版信息

Mediators Inflamm. 2016;2016:4578230. doi: 10.1155/2016/4578230. Epub 2016 Mar 17.

Abstract

Multiple sclerosis is the most common autoimmune disease of the central nervous system. It is believed that the increased migration of autoreactive lymphocytes across the blood-brain barrier (BBB) may be responsible for axonal demyelination of neurons. In this review, we discuss microRNAs participating in the pathological processes of MS, including periphery inflammation, blood-brain barrier disruption, and CNS lesions, and in its therapeutic response, in order to find biomarkers of disease severity and to predict the response to therapy of the diseases.

摘要

多发性硬化症是中枢神经系统最常见的自身免疫性疾病。据信,自身反应性淋巴细胞穿越血脑屏障(BBB)的迁移增加可能是神经元轴突脱髓鞘的原因。在这篇综述中,我们讨论了参与多发性硬化症病理过程(包括外周炎症、血脑屏障破坏和中枢神经系统病变)及其治疗反应的微小RNA,以便找到疾病严重程度的生物标志物并预测疾病的治疗反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cced/4814683/cf7c36c7130a/MI2016-4578230.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验